Tag: Relyvrio

[ad_1] One of many few therapies the Meals and Drug Administration has accepted for amyotrophic lateral sclerosis has failed a big scientific trial, and its producer mentioned Friday that it was contemplating whether or not to withdraw it from the market. The remedy, referred to as Relyvrio, was accepted lower than two years in the…